| [1] |
GUO Zhiyu, CAO Tianyu, WANG Weidong, GUO Xingxian, MA Wanqi, LU Yuanyuan, ZHAO Xiaodi, JI Gang.
Correlation between blood lipid levels and survival prognosis of gastric cancer patients under operation: A retrospective cohort study
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 687-693.
|
| [2] |
XUAN Wenzhen, GONG Jianmin, LI Na.
Incidence,mortality,and disease burden of cervical cancer in China,1990—2021: trends over the past 30 years and future prediction
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 694-700.
|
| [3] |
LU Tingting, SHI Lijun, LIU Yingzhao, LIANG Huiting, WANG Qi.
Down⁃regulation of α2⁃macroglobulin expression activates TGF⁃β/SMADs signaling pathway to induce cisplatin resistance in ovarian cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 707-714.
|
| [4] |
LI Siyuan, ZHANG Yan, ZHANG Lu.
Application and challenge of CAR-T cell therapy in autoimmune diseases
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 516-524.
|
| [5] |
LI Yixue, LI Yajun, Zeng Ruolan, HE Yizi, WANG Caiqin, XIAO Ling, ZHOU Hui.
Current status of CAR-T therapy for multiple myeloma: Challenges and hopes coexist
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 392-398.
|
| [6] |
XIAO Wanting, ZHANG Chunyan, TIAN Biao, GAO Yaya, GAO Guangxun.
A novel immunotherapy strategy for relapsed/refractory multiple myeloma: GPRC5D bispecific antibody
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 399-404.
|
| [7] |
ZHANG Wenhai, LIAN Bin, HOU Qinhan, LIANG Xinguang, YANG Qiujiao, LIANG Ling, CHEN Binjie, WEI Changyuan.
Construction and validation of nomogram model for predicting the relatively long-term survival of metastatic breast cancer based on SEER database
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 454-461.
|
| [8] |
XIE Changquan, HE Fengyi, LU Guodong, LI Qiuyun.
Andrographolide combined with doxorubicin induces cell death in breast cancer cell via ROS-dependent DNA damage
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 302-307.
|
| [9] |
HOU Naiqiao, ZHAI Wei, ZHENG Junhua.
Application status and challenges of artificial intelligence in digital pathology of renal cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 143-151.
|
| [10] |
NIU Shengli, LIU Bowei.
Effects of high sodium diet on the burden of gastric cancer in Chinese residents and a trend analysis,1990—2019
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 186-192.
|
| [11] |
MA Fuchao, LIU Aiquan, XIE Weishun, SHEN Yanhua, FENG Jie, JIANG Qi, GE Lianying.
Screening and diagnostic efficacy evaluation of risk miRNAs during the development of gastric cancer: a multicenter study
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 193-199.
|
| [12] |
CHEN Lijun, LIANG Xiumei, WU Yun, LU Xiangning, XIE Ganglin, YANG Zhijun.
A survival report of 78,046 patients with malignant tumor from a hospital?based cancer registry database
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 229-237.
|
| [13] |
LONG Yuhao, ZHENG Bohao, ZHOU Shengtao.
Effect of m6A modification on ovarian cancer and its value as a potential therapeutic target
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 238-242.
|
| [14] |
WANG Huilin, JIANG Wei, YU Qitao.
Progress in the application of patient?reported outcomes in tumor immunotherapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 255-260.
|
| [15] |
ZHOU Xinmeng, LIAO Qingqing, XIE Na, HUANG Canhua, SUN Xiaodong, ZHANG Yuanyuan.
Inventory of tumor protein marker research progress in 2023
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 23-31.
|
